共 125 条
- [1] Falade-Nwulia O(2017)Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review Ann Intern Med 166 637-648
- [2] Suarez-Cuervo C(2016)Drugs: is next generation the last generation? Gastroenterology 151 587-590
- [3] Nelson D(2016)Second generation direct-acting antivirals - do we expect major improvements? J Hepatol 65 S130-Ss42
- [4] Fried M(2013)Epidemiology and natural history of hepatitis C virus infection Nat Rev Gastroenterol Hepatol 10 553-562
- [5] Segal J(2011)The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection Clin Infect Dis 52 793-800
- [6] Sulkowski M(2014)The hepatitis C cascade of care: identifying priorities to improve clinical outcomes PLoS One 9 e97317-195
- [7] Pawlotsky JM(2016)The population level cascade of care for hepatitis C in British Columbia, Canada:the BC hepatitis testers cohort (BC-HTC) EBioMedicine 12 189-168
- [8] Hepatitis C(2017)Managing expense and expectation in a treatment revolution: problematizing prioritisation through an exploration of hepatitis C treatment 'benefit' Int J Drug Policy 47 161-562
- [9] Feld JJ(2013)Cobos JPdL. Patient-reported outcome measures: are they patient-generated, patient-centred or patient-valued? J Ment Health 22 555-108
- [10] Foster GR(2017)Patient-reported outcomes - harnessing patients' voices to improve clinical care N Engl J Med 376 105-317